ArticleOrthopaedic journal of sports medicine2026
Correlation of Social Determinants of Health Disparities With Outcomes After Bankart Repair: A Large Database Study.
Article in Orthopaedic journal of sports medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The correlation of social determinants of health disparities (SDHD) on outcomes after Bankart repair (BR) remains unclear. Purpose/Hypothesis: The purpose of this study was to compare 90-day adverse events, health care utilization (physical therapy [PT] use, emergency department [ED] visits, and readmissions), and overall 90-day health care costs between patients with and without SDHD after primary BR. Secondary outcomes included 2-year complications (shoulder stiffness and subsequent ipsilateral shoulder surgery) between study groups. The authors hypothesized that SDHD patients would be at a higher risk of complications and greater health care utilization. Study Design: Cohort study; Level of evidence, 3. Methods: Primary BR patients were identified from the PearlDiver M165 database from January 2010 through October 2022. The exclusion criteria included a history of neoplasm or infection within 90 days before the procedure, or inactivity in the database for 90 days postoperatively. Patients with SDHD within 1 year before surgery were identified with administrative coding. Patients with and without SDHD were matched (1:4) based on age, sex, surgery type (open vs arthroscopic), and the Elixhauser Comorbidity Index (a measure of comorbidity burden). Also, 90-day adverse events, PT utilization, ED visits, and readmissions were compared using multivariable logistic regression, controlling for all matching variables. Overall, 90-day reimbursements for arthroscopic BR were compared using a Wilcoxon rank sum test. Two-year postoperative shoulder stiffness and subsequent ipsilateral shoulder surgery were compared with multivariable analyses. Results: Of 142,594 BR patients, SDHD was identified in 4946 (3.5%). After the match, 4501 SDHD patients and 17,769 non-SDHD patients were selected. Multivariable logistic regression revealed that SDHD patients had a similar risk for all assessed individual and aggregated adverse events relative to non-SDHD patients. However, SDHD patients had higher PT utilization (odds ratio [OR], 1.22), ED visits (OR, 1.29), and total reimbursements (median [Q1-Q3]: $4446 [$2357-$7812] vs $3388 [$1765-$5919]) within 90 days postoperative ( Conclusion: Our study demonstrated that SDHD patients undergoing BR experienced comparable 90-day medical complications, but greater health care utilization, higher costs, and 2-year stiffness risk. Further prospective research is warranted to elucidate effective targeted interventions that may mitigate these disparities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.